Section of Otolaryngology, Department of Surgery, School of Medicine, Yale University, New Haven, Connecticut, USA.
Section of Otolaryngology, Department of Surgery, School of Medicine, Yale University, Yale-New Haven Hospital, Yale Cancer Center, New Haven, Connecticut, USA.
Otolaryngol Head Neck Surg. 2019 Dec;161(6):986-992. doi: 10.1177/0194599819874315. Epub 2019 Sep 3.
To determine national positive margin rates in transoral laser microsurgery, to compare patients with positive and negative margins, and to identify factors associated with positive margins.
Retrospective review of the National Cancer Database.
Population based.
SUBJECTS/METHODS: Patients included those with TIS-T3 laryngeal squamous cell carcinoma (2004-2014). Univariable and multivariable logistic regression were used to identify predictors.
A total of 1959 patients met inclusion criteria. The national positive margin rate was 22.3%. Sixty-five percent of patients had T1 disease; 94.3% were N-negative; and 74.0% had glottic tumors. Fifty-eight percent of patients were treated at academic centers, and 60.6% were treated at facilities performing <2 cases per year. On multivariable analysis, factors associated with margin status included facility volume (odds ratio [95% CI]; in cases per year: 0.93 [0.89-0.97], = .001), academic status (vs nonacademic; academic: 0.70 [0.54-0.90], = .008), T-stage (vs T1; T2: 2.74 [2.05-3.65], T3: 5.53 [3.55-8.63], TIS: 0.59 [0.38-0.92], < .001), and N-stage (vs N0; N1: 3.42 [1.79-6.54], N2: 2.01 [1.09-3.69], < .001). Tumor subsite was not associated with margin status.
The national positive margin rate for laryngeal laser surgery is 22%, which is concerning given the equivalent survival benefit offered by surgery and primary radiation and the increased likelihood of bimodal therapy in the situation of positive margins. Cases treated at nonacademic centers and those with lower caseloads had a higher likelihood of positive margins. There was a linear association between T-stage and likelihood of positive margins, with T3 tumors being 5 times as likely as T1 to yield positive margins. This study highlights the importance of proper patient selection for transoral laser microsurgery resections.
确定经口激光微创手术中的全国阳性切缘率,比较阳性和阴性切缘患者,并确定与阳性切缘相关的因素。
国家癌症数据库的回顾性研究。
基于人群。
受试者/方法:纳入的患者包括 TIS-T3 喉鳞状细胞癌患者(2004-2014 年)。采用单变量和多变量逻辑回归来确定预测因素。
共有 1959 名患者符合纳入标准。全国阳性切缘率为 22.3%。65%的患者为 T1 期疾病;94.3%为 N-阴性;74.0%为声门肿瘤。58%的患者在学术中心接受治疗,60.6%的患者在每年手术量<2 例的机构接受治疗。多变量分析显示,与切缘状态相关的因素包括机构容量(比值比[95%CI];每年病例数:0.93[0.89-0.97],.001)、学术地位(与非学术地位相比;学术地位:0.70[0.54-0.90],.008)、T 期(与 T1 相比;T2:2.74[2.05-3.65],T3:5.53[3.55-8.63],TIS:0.59[0.38-0.92],.001)和 N 期(与 N0 相比;N1:3.42[1.79-6.54],N2:2.01[1.09-3.69],.001)。肿瘤部位与切缘状态无关。
喉激光手术的全国阳性切缘率为 22%,考虑到手术和原发性放疗提供的等效生存获益,以及在阳性切缘情况下双模式治疗的可能性增加,这一比例令人担忧。在非学术中心治疗的病例和手术量较低的病例中,阳性切缘的可能性更高。T 期与阳性切缘的可能性呈线性关系,T3 肿瘤的阳性切缘可能性是 T1 肿瘤的 5 倍。本研究强调了对经口激光微创手术切除进行适当的患者选择的重要性。